|
Dolutegravir + Doravirine Nuke Sparing for PWH with Severe Kidney Disease, PK, Drug Levels
|
|
|
Download the PDF
Download the PDF
Download the PDF
Efficacy and safety of dolutegravir and doravirine dual therapy
in the context of antiretroviral therapy switch:
48 weeks analysis

The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir

A 2-Way Steady State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
https://www.natap.org/2015/Pharm/Pharm_40.htm

published - A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir



|
|
|
|
|
|
|